Close Menu

Not Just an X-ray

At the Decision Tree, Thomas Goetz blogs that he is "fearful" that with all the interest by Congress in personal genetic testing that "the FDA will feel obligated to regulate and shut us off from what is rightfully ours." Goetz adds that "this isn't a drug, and this isn't a device — it's information about ourselves" and that it provides consumers with the ability "to take control of their health."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.